Pancreatic carcinoma as a sequel to therapy of lymphoma
β Scribed by Peter R. Jochimsen; Nathan W. Pearlman; Richard L. Lawton
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 262 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Development of a carcinoma in the pancreas of a young man who had five years previously undergone intensive radiotherapy and subsequent chemotherapy for treatment of a lymphoma suggests that induction of the second neoplasm occurred as the result of the therapy of the first. While definitive proof of causality is lacking, a review of recent literature strongly suggests that the association noted in the patient described is more than serendipitous. Increased usage of highβdose radiotherapy, particularly in conjunction with chemotherapy, may be directly related, and it is imperative that such an association be kept in mind when such patients are seen in followβup.
π SIMILAR VOLUMES
## Abstract The effects of __E. coli__ Lβasparaginase on cultured human pancreatic carcinoma (MIA PaCaβ2) have been studied. The enzyme (1 U/ml) inhibited growth and protein synthesis in both MIA PaCaβ2 and PANCβ1, another pancreatic carcinoma cell line, but had little or no effect on human breast
We tested the effectiveness of dihydroxyanthracenedione (DHAD) on cell growth of two human pancreatic carcinoma cell lines MIA PaCa-2 and PANC-1. At the level of ID,,, the drug was almost equally effective against both cell lines. When the time exposure of MIA PaCa-2 cells to the drug was increased